📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
GLAXOSMITHKLINE PHARMACEUTICALS LTD.GLAXOPharmaceuticals
Open
2379
High
2379.2
Low
2314
Close
2320.7
Volume
106325
Exchange
nse
Time
21-May-2026

Outlook

Score:  

3.5

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Glaxosmithkline Pharmaceuticals is  
Opening Marubozu
Estimated Stoploss of Glaxosmithkline Pharmaceuticals is ₹  
2379.2
Glaxosmithkline Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
Opening Marubozu
 candle pattern indicates Glaxosmithkline Pharmaceuticals has chances of  
Continuationℹ
 of the current trend. 

Trend

Glaxosmithkline Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Glaxosmithkline Pharmaceuticals is  
Downℹ
 by  

3.51

%. 
Target
Buy @ 

2246.88

Sell @ 

2619.92

Current @ 

2320.7

Volume

The trades of Glaxosmithkline Pharmaceuticals have been in  
Immenseℹ
 volume. 
The volume trades for Glaxosmithkline Pharmaceuticals are  
Bearishℹ
 with  
Strong Sellersℹ
The trade volume of Glaxosmithkline Pharmaceuticals is  

Up

 by  

68.76

% 

Valuation

The current market price of Glaxosmithkline Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 4108cr and total assets worth ₹ 4108cr, the balance sheet of Glaxosmithkline Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Glaxosmithkline Pharmaceuticals has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 474cr

. It is  
Upℹ
 by  

1534.48

%. 

(*Mar 2025)

61.29% i.e. ₹ 1289cr earned in operatingℹ
2.14% i.e. ₹ 45cr spent in investingℹ
36.57% i.e. ₹ 769cr spent in financingℹ
0% in otherℹ
Glaxosmithkline Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 29cr

. It is  
Upℹ
 by  

111.55

%. 

(*Mar 2024)

50.56% i.e. ₹ 582cr earned in operatingℹ
0.7% i.e. ₹ 8cr earned in investingℹ
48.74% i.e. ₹ 561cr spent in financingℹ
0% in otherℹ
Income
The income of Glaxosmithkline Pharmaceuticals is  

₹ 1013cr

 and  

Profit

 is :  

₹ 257cr

(*Sep 2025)

Glaxosmithkline Pharmaceuticals Profit is up by:  

25.37

% and Income is Up by:  

19.46

% 

(*Sep 2025)

The income of Glaxosmithkline Pharmaceuticals is  

₹ 848cr

 and  

Profit

 is :  

₹ 205cr

(*Jun 2025)

Glaxosmithkline Pharmaceuticals Profit is down by:  

21.76

% and Income is Down by:  

16.45

% 

(*Jun 2025)

The income of Glaxosmithkline Pharmaceuticals is  

₹ 1015cr

 and  

Profit

 is :  

₹ 262cr

(*Mar 2025)

Glaxosmithkline Pharmaceuticals Profit is up by:  

14.41

% and Income is Up by:  

3.15

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.